A. Iwata et al., Gene therapy of transplant arteriopathy by liposome-mediated transfection of endothelial nitric oxide synthase, J HEART LUN, 19(11), 2000, pp. 1017-1028
Background: Transplant arteriopathy is the major factor limiting long-term
survival after cardiac transplantation. We have previously demonstrated tha
t liposome-mediated gene delivery of endothelial nitric oxide synthase (eNO
S) to donor hearts reduces ischemia-reperfusion injury by blocking NF kappa
B activation, adhesion molecule expression, and leukocyte infiltration. In
this study, we used gene transfer of eNOS in a rabbit carotid transplant mo
del to see whether these same effects would similarly ameliorate transplant
arteriopathy.
Methods: Liposomes complexed to the gene encoding eNOS were injected into d
onor carotid arterial segments that were transplanted orthotopically into r
ecipient carotid arteries (n = 10), Controls included transplanted carotids
transfected with liposomes complexed to empty plasmids (no functional gene
) (n = 4) and transplanted carotids treated with saline (n = 6), Transplant
ed arteries were harvested for processing at 21 days. Intima/media (I/M) ar
ea ratios were calculated by computerized image analysis. Infiltrating T-ly
mphocytes and macrophages, and expression of VCAM-1 and ICAM-1 were quantif
ied on immunocytochemistry.
Results: The I/M ratio was significantly reduced in eNOS-transfected arteri
es compared with arteries transfected with empty plasmids and saline-treate
d controls. Compared to transplanted control arteries, eNOS-transfected art
eries demonstrated significantly reduced T-cell infiltration into the intim
a and significantly reduced macrophage infiltration into the media, Cell su
rface expression of VCAM-1 and ICAM-1 were both reduced in eNOS-transfected
arteries.
Conclusions: ENOS gene delivery can suppress neointimal lesion formation an
d T-lymphocyte and macrophage infiltration in transplanted arteries, associ
ated with a reduction in relevant adhesion molecule expression. Thus, gene
therapy with eNOS may not only reduce ischemia-reperfusion injury but may a
lso ameliorate transplant arteriopathy in transplanted hearts.